Granahan Investment Management trimmed its stake in AnaptysBio, Inc. and set a $90.00 target price on shares.
1 report, 1 independent
Updated Jun 17
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Granahan Investment Management trimmed its stake in AnaptysBio, Inc. and set a $90.00 target price on shares.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Leerink partners
U.S. investment bank